200
Participants
Start Date
September 15, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
COVID-19
The COVID-19 infection situation was used as an intervention measure, and the cohort was divided into groups.
Zhejiang Hospital, Department of Oncology, Hangzhou, China, 310030, Hangzhou
Zhejiang Hospital
OTHER